Glucose transport in the heart
- PMID: 14766360
- DOI: 10.2741/1216
Glucose transport in the heart
Abstract
The heart is a unique organ in many ways. It consists of specialized muscle cells (cardiomyocytes), which are adapted to contract constantly in a coordinated fashion. This is vital to the survival of the organism given the central role of the heart in the maintenance of the cardiovascular system that delivers oxygen, metabolic substrates and hormones to the rest of the body. In order for the heart to maintain its function it must receive a constant supply of metabolic substrates, to generate ATP to maintain contractile function, without fatigue. Thus the heart is capable of utilizing a variety of metabolic substrates and is able to rapidly adapt its substrate utilization in the face of changes in substrate supply. The major metabolic substrate for the heart is fatty acids. However, up to 30% of myocardial ATP is generated by glucose and lactate, with smaller contributions from ketones and amino acids. Although glucose is not the major metabolic substrate in the heart at rest, there are many circumstances in which it assumes greater importance such as during ischemia, increased workload and pressure overload hypertrophy. Like all other cells, glucose is transported into cardiac myocytes by members of the family of facilitative glucose transporters (GLUTs). In this regard, cardiomyocytes bear many similarities to skeletal muscle, but there are also important differences. For example, the most abundant glucose transporter in the heart is the GLUT4 transporter, in which translocation to the plasma membrane represents an important mechanism by which the net flux of glucose into the cell is regulated. Because cardiomyocytes are constantly contracting it is likely that contraction mediated GLUT4 translocation represents an important mechanism that governs the entry of glucose into the heart. While this is also true in skeletal muscle, because many muscles are often at rest, insulin mediated GLUT4 translocation represents a quantitatively more important mechanism regulating skeletal muscle glucose uptake than is the case in the heart. In contrast to skeletal muscle, where most GLUT1 is in perineural sheaths (1), in the heart there is significant expression of GLUT1 (2), which under certain circumstances is responsible for a significant component of basal cardiac glucose uptake. This review will summarize the current state of knowledge regarding the regulation of glucose transporter expression, and the regulation of glucose transport into myocardial cells.
Similar articles
-
Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4.Biochem J. 1993 Oct 1;295 ( Pt 1)(Pt 1):287-93. doi: 10.1042/bj2950287. Biochem J. 1993. PMID: 8216230 Free PMC article.
-
Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.J Clin Invest. 1999 Dec;104(12):1703-14. doi: 10.1172/JCI7605. J Clin Invest. 1999. PMID: 10606624 Free PMC article.
-
Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes.Am J Cardiol. 1997 Aug 4;80(3A):65A-76A. doi: 10.1016/s0002-9149(97)00459-1. Am J Cardiol. 1997. PMID: 9293957 Review.
-
Insulin-sensitive regulation of glucose transport and GLUT4 translocation in skeletal muscle of GLUT1 transgenic mice.Biochem J. 1999 Jan 1;337 ( Pt 1)(Pt 1):51-7. Biochem J. 1999. PMID: 9854024 Free PMC article.
-
Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters.Pflugers Arch. 2004 Apr;448(1):1-15. doi: 10.1007/s00424-003-1199-4. Epub 2004 Feb 10. Pflugers Arch. 2004. PMID: 14872244 Review.
Cited by
-
Cardiac Metabolism and MiRNA Interference.Int J Mol Sci. 2022 Dec 20;24(1):50. doi: 10.3390/ijms24010050. Int J Mol Sci. 2022. PMID: 36613495 Free PMC article. Review.
-
The Impact of Energy Substrates, Hormone Level and Subject-Related Factors on Physiologic Myocardial (18)F-FDG Uptake in Normal Humans.Nucl Med Mol Imaging. 2013 Dec;47(4):225-31. doi: 10.1007/s13139-013-0230-8. Epub 2013 Sep 6. Nucl Med Mol Imaging. 2013. PMID: 24900117 Free PMC article.
-
A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.Heart Fail Rev. 2017 Nov;22(6):825-842. doi: 10.1007/s10741-017-9623-6. Heart Fail Rev. 2017. PMID: 28536966 Review.
-
Metabolomic and transcriptomic signatures of chemogenetic heart failure.Am J Physiol Heart Circ Physiol. 2022 Mar 1;322(3):H451-H465. doi: 10.1152/ajpheart.00628.2021. Epub 2022 Jan 28. Am J Physiol Heart Circ Physiol. 2022. PMID: 35089810 Free PMC article.
-
Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond.Cardiovasc Res. 2024 Dec 14;120(16):1996-2016. doi: 10.1093/cvr/cvae231. Cardiovasc Res. 2024. PMID: 39453987 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous